\-\ Texto\\:\\ \ \(0\)\
\-\ hypotensive\\ diaphoretic\\ woman\ \(0\)\
\-\ conservative\ \(240\)\
\-\ \\â\\€\\¢\\ type\\ a\\ aortic\\ dissection\ \(0\)\
\-\ \\â\\€\\¢\\ dissection\\ extends\\ into\\ both\\ common\\ carotid\\ arteries\\.\ \(0\)\
\-\ \\â\\€\\¢\\ paraclinoid\\ aneurysm\\ of\\ the\\ right\\ internal\\ carotid\\ artery\ \(0\)\
\-\ marfan\\'s\\ syndrome\\,\\ aortic\\ dissection\\,\\ cerebral\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ aortic\\ dissection\\ \\-\\ other\\ types\ \(0\)\
\-\ \\â\\€\\¢\\ mycotic\\ aneurysm\ \(1\)\
\-\ 53\\ year\\ old\\ woman\\ with\\ marfan\\ syndrome\\.\\ \\ she\\ presents\\ now\\ with\\ sudden\\ onset\\ of\\ chest\\ pain\\.\ \(0\)\
\-\ there\\ is\\ a\\ history\\ of\\ debate\\ as\\ to\\ whether\\ marfan\\'s\\ syndrome\\ is\\ associated\\ with\\ intracranial\\ aneurysms\\.\\ \\ marfan\\'s\\ results\\ from\\ a\\ defect\\ in\\ fibrillin\\,\\ which\\ is\\ a\\ glycoprotein\\ that\\ is\\ a\\ major\\ component\\ of\\ microfibrils\\.\\ \\ the\\ microfibrils\\ are\\ distributed\\ in\\ the\\ elastic\\ tissues\\ \\(including\\ arterial\\ walls\\)\\ throughout\\ the\\ body\\ suggesting\\ their\\ defect\\ could\\ result\\ in\\ aneurysm\\ development\\.\\ \ \(0\)\
\-\ several\\ case\\ reports\\ have\\ described\\ intracranial\\ aneurysms\\ in\\ marfan\\'s\\ patients\\,\\ and\\ this\\ lead\\ to\\ a\\ variety\\ of\\ studies\\.\\ \\ a\\ neuropathologic\\ study\\ by\\ schievink\\ et\\ al\\ of\\ 7\\ marfan\\'s\\ patients\\ found\\ intracranial\\ aneurysms\\ in\\ 2\\.\\ \\ however\\,\\ this\\ study\\ was\\ limited\\ by\\ small\\ population\\ size\\.\\ \\ another\\ study\\ by\\ van\\ den\\ berg\\ et\\ al\\ of\\ 135\\ patients\\ in\\ a\\ marfan\\'s\\ clinic\\ did\\ not\\ find\\ an\\ increase\\ in\\ symptomatic\\ intracranial\\ aneurysms\\ based\\ on\\ absence\\ of\\ subarachnoid\\ hemorrhage\\;\\ however\\,\\ no\\ neuroimaging\\ was\\ performed\\.\\ in\\ 1999\\,\\ a\\ study\\ by\\ conway\\ et\\ al\\,\\ reviewed\\ autopsy\\ results\\ in\\ 25\\ confirmed\\ marfan\\'s\\ patients\\.\\ \\ only\\ one\\ of\\ these\\ patients\\ had\\ an\\ intracranial\\ aneurysm\\,\\ which\\ they\\ report\\ is\\ not\\ statistically\\ different\\ from\\ the\\ general\\ autopsy\\ population\\.\\ their\\ conclusion\\ was\\ that\\ there\\ is\\ no\\ increased\\ prevalence\\ of\\ intracranial\\ aneurysms\\ in\\ marfan\\'s\\ patients\\,\\ and\\ these\\ patients\\ do\\ not\\ require\\ routine\\ screening\\ of\\ the\\ intracranial\\ vasculature\\.\ \(0\)\
\-\ in\\ addition\\,\\ \\ murdoch\\ et\\ al\\ evaluated\\ of\\ the\\ cause\\ of\\ death\\ of\\ 56\\ marfan\\'s\\ patients\\,\\ none\\ of\\ which\\ was\\ from\\ intracranial\\ aneurysm\\.\\ \\ \\ \\ these\\ patients\\ typically\\ have\\ a\\ shorter\\ life\\ expectancy\\ \\(mean\\ 39\\ years\\,\\ median\\ 38\\ years\\ in\\ one\\ autopsy\\ series\\)\\.\\ \\ aortic\\ dissection\\,\\ aortic\\ rupture\\ or\\ cardiac\\ failure\\ due\\ to\\ mitral\\ and\\ aortic\\ valve\\ regurgitation\\ are\\ reported\\ as\\ the\\ main\\ causes\\ of\\ patient\\ death\\.\ \(0\)\
\-\ conway\\ et\\ al\\.\\ marfan\\ syndrome\\ is\\ not\\ associated\\ with\\ intracranial\\ aneurysms\\.\\ stroke\\ 1999\\;\\ 30\\:1632\\-1636\ \(0\)\
\-\ van\\ den\\ berg\\ jsp\\ et\\ al\\.\\ is\\ marfan\\ syndrome\\ associated\\ with\\ symptomatic\\ intracranial\\ aneurysms\\?\\ stroke\\ 1996\\;\\ 27\\:\\ 10\\-12\ \(0\)\
\-\ schieving\\ wi\\ et\\ al\\.\\ intracranial\\ aneurysms\\ in\\ marfan\\'s\\ syndrome\\:\\ an\\ autopsy\\ study\\.\\ neurosurgery\\ 1997\\;\\ 41\\:\\ 866\\-871\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ marfan\\:\\ 0\\.1777794972065402\ \(0\)\
\-\ aneurysms\\:\\ 0\\.09718746862279738\ \(0\)\
\-\ intracranial\\:\\ 0\\.0941389315303003\ \(0\)\
\-\ al\\:\\ 0\\.060089883913587716\ \(0\)\
\-\ et\\:\\ 0\\.05801371803520373\ \(0\)\
\-\ autopsy\\:\\ 0\\.05727895451873666\ \(0\)\
\-\ dissection\\:\\ 0\\.04976774771475401\ \(0\)\
\-\ aortic\\:\\ 0\\.04917913008475572\ \(0\)\
\-\ aneurysm\\:\\ 0\\.04802046135132658\ \(0\)\
\-\ patients\\:\\ 0\\.04716628292486785\ \(0\)\
\-\ \\'s\\:\\ 0\\.04464565446367405\ \(0\)\
\-\ microfibrils\\:\\ 0\\.04177970817045734\ \(0\)\
\-\ den\\:\\ 0\\.03849465044268509\ \(0\)\
\-\ berg\\:\\ 0\\.03849465044268509\ \(0\)\
\-\ conway\\:\\ 0\\.036573014859234074\ \(0\)\
\-\ syndrome\\:\\ 0\\.03474748687300438\ \(0\)\
\-\ study\\:\\ 0\\.03331316773530757\ \(0\)\
\-\ van\\:\\ 0\\.028945347027792834\ \(0\)\
\-\ 1999\\:\\ 0\\.02296315881712975\ \(0\)\
\-\ death\\:\\ 0\\.021852254997988308\ \(0\)\
\-\ population\\:\\ 0\\.02113179903922705\ \(0\)\
\-\ stroke\\:\\ 0\\.02113179903922705\ \(0\)\
\-\ paraclinoid\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ fibrillin\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ neuropathologic\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ schievink\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ murdoch\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ 30\\:1632\\-1636\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ jsp\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ schieving\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ wi\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ 866\\-871\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ 10\\-12\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ \\;\\:\\ 0\\.019198305103816055\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.018566520753505778\ \(0\)\
\-\ glycoprotein\\:\\ 0\\.018286507429617037\ \(0\)\
\-\ carotid\\:\\ 0\\.01816071944198181\ \(0\)\
\-\ their\\:\\ 0\\.017726751700154843\ \(0\)\
\-\ diaphoretic\\:\\ 0\\.017604796357456418\ \(0\)\
\-\ 135\\:\\ 0\\.017076020169508054\ \(0\)\
\-\ statistically\\:\\ 0\\.017076020169508054\ \(0\)\
\-\ expectancy\\:\\ 0\\.01664397856573091\ \(0\)\
\-\ results\\:\\ 0\\.016348542222486478\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01608996883741333\ \(0\)\
\-\ these\\:\\ 0\\.01580932245467659\ \(0\)\
\-\ debate\\:\\ 0\\.0156831607740054\ \(0\)\
\-\ elastic\\:\\ 0\\.0156831607740054\ \(0\)\
\-\ defect\\:\\ 0\\.015159939935070744\ \(0\)\
\-\ hypotensive\\:\\ 0\\.015001449701844782\ \(0\)\
\-\ conclusion\\:\\ 0\\.014636163730690143\ \(0\)\
\-\ shorter\\:\\ 0\\.014636163730690143\ \(0\)\
\-\ associated\\:\\ 0\\.014335041909296459\ \(0\)\
\-\ distributed\\:\\ 0\\.014319738629684164\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.014176078388412993\ \(0\)\
\-\ by\\:\\ 0\\.013486927992842415\ \(0\)\
\-\ reviewed\\:\\ 0\\.01345977300482784\ \(0\)\
\-\ find\\:\\ 0\\.013262186253787436\ \(0\)\
\-\ mycotic\\:\\ 0\\.013169246175225156\ \(0\)\
\-\ in\\:\\ 0\\.01298143126024482\ \(0\)\
\-\ 1996\\:\\ 0\\.012677209765798038\ \(0\)\
\-\ mean\\:\\ 0\\.012604291143364971\ \(0\)\
\-\ prevalence\\:\\ 0\\.012464858678855651\ \(0\)\
\-\ regurgitation\\:\\ 0\\.012464858678855651\ \(0\)\
\-\ mitral\\:\\ 0\\.012398103046233148\ \(0\)\
\-\ variety\\:\\ 0\\.011977057602542501\ \(0\)\
\-\ years\\:\\ 0\\.011892147568807975\ \(0\)\
\-\ median\\:\\ 0\\.01171639197407253\ \(0\)\
\-\ not\\:\\ 0\\.011704442386179483\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.01139380388325599\ \(0\)\
\-\ 1997\\:\\ 0\\.011351106002917888\ \(0\)\
\-\ which\\:\\ 0\\.011339890430634231\ \(0\)\
\-\ however\\:\\ 0\\.011276625855910287\ \(0\)\
\-\ vasculature\\:\\ 0\\.010997941123390666\ \(0\)\
\-\ one\\:\\ 0\\.010975030252657081\ \(0\)\
\-\ 53\\:\\ 0\\.010926127498994154\ \(0\)\
\-\ whether\\:\\ 0\\.010891020660640738\ \(0\)\
\-\ 38\\:\\ 0\\.010788716935841667\ \(0\)\
\-\ 41\\:\\ 0\\.010788716935841667\ \(0\)\
\-\ is\\:\\ 0\\.010659540822459254\ \(0\)\
\-\ 56\\:\\ 0\\.010658839598175802\ \(0\)\
\-\ types\\:\\ 0\\.010334528738656375\ \(0\)\
\-\ walls\\:\\ 0\\.010334528738656375\ \(0\)\
\-\ valve\\:\\ 0\\.01012375270544193\ \(0\)\
\-\ series\\:\\ 0\\.010073863110186404\ \(0\)\
\-\ different\\:\\ 0\\.01002500224003774\ \(0\)\
\-\ suggesting\\:\\ 0\\.009839050544678749\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.009839050544678749\ \(0\)\
\-\ lead\\:\\ 0\\.009708577139031761\ \(0\)\
\-\ major\\:\\ 0\\.009467385920287823\ \(0\)\
\-\ main\\:\\ 0\\.009429470419466873\ \(0\)\
\-\ 39\\:\\ 0\\.009410737766606416\ \(0\)\
\-\ a\\:\\ 0\\.009398099569161166\ \(0\)\
\-\ 27\\:\\ 0\\.009392152038025785\ \(0\)\
\-\ was\\:\\ 0\\.009367559452262435\ \(0\)\
\-\ sudden\\:\\ 0\\.00935541225950454\ \(0\)\
\-\ woman\\:\\ 0\\.009354990272459273\ \(0\)\
\-\ evaluated\\:\\ 0\\.009283598635108026\ \(0\)\
\-\ require\\:\\ 0\\.00926598020267315\ \(0\)\
\-\ component\\:\\ 0\\.009248491796754613\ \(0\)\
\-\ report\\:\\ 0\\.009064184448312232\ \(0\)\
\-\ clinic\\:\\ 0\\.009048118839342142\ \(0\)\
\-\ from\\:\\ 0\\.009003097486878286\ \(0\)\
\-\ \\,\\:\\ 0\\.008980902647492947\ \(0\)\
\-\ arterial\\:\\ 0\\.008863375850077421\ \(0\)\
\-\ life\\:\\ 0\\.008833938598896005\ \(0\)\
\-\ development\\:\\ 0\\.008819355979051507\ \(0\)\
\-\ do\\:\\ 0\\.008790457227644355\ \(0\)\
\-\ extends\\:\\ 0\\.008776138946943022\ \(0\)\
\-\ have\\:\\ 0\\.008769848712630767\ \(0\)\
\-\ another\\:\\ 0\\.00870581722147829\ \(0\)\
\-\ screening\\:\\ 0\\.008637522343432102\ \(0\)\
\-\ described\\:\\ 0\\.008624096425101112\ \(0\)\
\-\ rupture\\:\\ 0\\.008597470659065742\ \(0\)\
\-\ addition\\:\\ 0\\.008584269130512532\ \(0\)\
\-\ limited\\:\\ 0\\.008545100168542838\ \(0\)\
\-\ general\\:\\ 0\\.008532186413169461\ \(0\)\
\-\ increase\\:\\ 0\\.008493862102160929\ \(0\)\
\-\ absence\\:\\ 0\\.008419024253700504\ \(0\)\
\-\ an\\:\\ 0\\.008400461120507558\ \(0\)\
\-\ arteries\\:\\ 0\\.008382473376151615\ \(0\)\
\-\ tissues\\:\\ 0\\.008311020679064677\ \(0\)\
\-\ 25\\:\\ 0\\.008185370280230031\ \(0\)\
\-\ reports\\:\\ 0\\.008163223686821885\ \(0\)\
\-\ routine\\:\\ 0\\.008119541929265396\ \(0\)\
\-\ conservative\\:\\ 0\\.008087301047616633\ \(0\)\
\-\ \\:\\:\\ 0\\.00803512902363032\ \(0\)\
\-\ failure\\:\\ 0\\.007932365599126462\ \(0\)\
\-\ \\?\\:\\ 0\\.007902558058351912\ \(0\)\
\-\ causes\\:\\ 0\\.007882892648838416\ \(0\)\
\-\ result\\:\\ 0\\.007768208902720289\ \(0\)\
\-\ 7\\:\\ 0\\.00775889781708074\ \(0\)\
\-\ based\\:\\ 0\\.007722015076461993\ \(0\)\
\-\ cardiac\\:\\ 0\\.007712883395618413\ \(0\)\
\-\ confirmed\\:\\ 0\\.0076146910025753495\ \(0\)\
\-\ throughout\\:\\ 0\\.007579969967535372\ \(0\)\
\-\ studies\\:\\ 0\\.0075627983833629385\ \(0\)\
\-\ could\\:\\ 0\\.007470516454574768\ \(0\)\
\-\ reported\\:\\ 0\\.007381693958710456\ \(0\)\
\-\ including\\:\\ 0\\.007311418580551953\ \(0\)\
\-\ did\\:\\ 0\\.007311418580551953\ \(0\)\
\-\ they\\:\\ 0\\.007296080868453333\ \(0\)\
\-\ typically\\:\\ 0\\.007147928363758229\ \(0\)\
\-\ cerebral\\:\\ 0\\.007015276070530974\ \(0\)\
\-\ that\\:\\ 0\\.00699516932966267\ \(0\)\
\-\ now\\:\\ 0\\.006922074857112909\ \(0\)\
\-\ cause\\:\\ 0\\.006851333238274802\ \(0\)\
\-\ type\\:\\ 0\\.0068261237638552385\ \(0\)\
\-\ internal\\:\\ 0\\.006788805382414151\ \(0\)\
\-\ size\\:\\ 0\\.006788805382414151\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.006739944512265488\ \(0\)\
\-\ body\\:\\ 0\\.006576454295471765\ \(0\)\
\-\ several\\:\\ 0\\.00650969866284926\ \(0\)\
\-\ 2\\.\\:\\ 0\\.006439441094313408\ \(0\)\
\-\ onset\\:\\ 0\\.006391993426362915\ \(0\)\
\-\ found\\:\\ 0\\.006381577285431546\ \(0\)\
\-\ as\\:\\ 0\\.006125959743574065\ \(0\)\
\-\ only\\:\\ 0\\.006088653219158615\ \(0\)\
\-\ artery\\:\\ 0\\.006029691924427013\ \(0\)\
\-\ there\\:\\ 0\\.0060270879453317005\ \(0\)\
\-\ she\\:\\ 0\\.00568432734941747\ \(0\)\
\-\ performed\\:\\ 0\\.005645920216178482\ \(0\)\
\-\ are\\:\\ 0\\.0055207292536947955\ \(0\)\
\-\ due\\:\\ 0\\.005403500362447487\ \(0\)\
\-\ common\\:\\ 0\\.005299211402740278\ \(0\)\
\-\ both\\:\\ 0\\.005171090025322563\ \(0\)\
\-\ none\\:\\ 0\\.005023032006891011\ \(0\)\
\-\ increased\\:\\ 0\\.004953755407108189\ \(0\)\
\-\ chest\\:\\ 0\\.004845329384022557\ \(0\)\
\-\ into\\:\\ 0\\.004818308928814472\ \(0\)\
\-\ other\\:\\ 0\\.004667389925835186\ \(0\)\
\-\ small\\:\\ 0\\.004664870342135353\ \(0\)\
\-\ this\\:\\ 0\\.004555152669735228\ \(0\)\
\-\ case\\:\\ 0\\.00443010529115467\ \(0\)\
\-\ of\\:\\ 0\\.004417205717459277\ \(0\)\
\-\ had\\:\\ 0\\.004369312367868977\ \(0\)\
\-\ \\-\\:\\ 0\\.004340588764711762\ \(0\)\
\-\ presents\\:\\ 0\\.004136597856653853\ \(0\)\
\-\ no\\:\\ 0\\.0040779343635251285\ \(0\)\
\-\ \\(\\:\\ 0\\.003423515290255263\ \(0\)\
\-\ \\)\\:\\ 0\\.003381695223285806\ \(0\)\
\-\ to\\:\\ 0\\.0030360292069406603\ \(0\)\
\-\ history\\:\\ 0\\.0027967169139978282\ \(0\)\
\-\ the\\:\\ 0\\.0026208395204478825\ \(0\)\
\-\ pain\\:\\ 0\\.0024730051363287555\ \(0\)\
\-\ or\\:\\ 0\\.0023732766563121033\ \(0\)\
\-\ year\\:\\ 0\\.0022656522968552482\ \(0\)\
\-\ right\\:\\ 0\\.002136568031067338\ \(0\)\
\-\ old\\:\\ 0\\.0020733047319010773\ \(0\)\
\-\ patient\\:\\ 0\\.0020298386988540002\ \(0\)\
\-\ on\\:\\ 0\\.0017153815458896401\ \(0\)\
\-\ \\.\\:\\ 0\\.0016824424690685437\ \(0\)\
\-\ with\\:\\ 0\\.0013863054039086461\ \(0\)\
\-\ and\\:\\ 0\\.0012796848748735908\ \(0\)\
